Likewise, the fraction of genome altered (FGA) was significantly lower in patients with BRAF alterations of a known functional class compared to the total of NSCLC patients, but did not show significant differences among the three BRAF classes (Figure 5B). Here, BRAF is linked to non-small cell lung carcinoma.